Emmessar Biotech and Nutrition Ltd
BSE:524768
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (25.6), the stock would be worth ₹0 (100% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0 | ₹27.28 |
0%
|
| Industry Average | 25.6 | ₹0 |
-100%
|
| Country Average | 23.3 | ₹0 |
-100%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Emmessar Biotech and Nutrition Ltd
BSE:524768
|
136.3m INR | 0 | 0 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
870.6B USD | 30.4 | 42.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
544.4B USD | 21.2 | 25.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 12.9 | 19.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
225.4B GBP | 22.5 | 28.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 15.9 | 19.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
279.4B USD | 11.6 | 15.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 970 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 9.4 | 10.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.4B USD | 10.1 | 19.6 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.4B USD | 8.8 | 16.8 |
Market Distribution
Other Multiples
Emmessar Biotech and Nutrition Ltd
Glance View
Emmessar Biotech & Nutrition Ltd. engages in the manufacturing and marketing of healthcare and nutritional products. The company is headquartered in Mumbai, Maharashtra. The firm is engaged in the manufacturing and marketing healthcare and nutritional products. Its segments include Healthcare, Fine Chemicals, and Rent on leasehold land. The Company’s product category includes Bone Care, General Health, Muscle Care, Pain Relief, Sexual Health, Skin Care and Skin Cure. Its products include CalmCream, CalmCream RESQ, Cute-N-Comely Cream, Frejomus Capsules, MagiCream, MSM Powder, PsoriBalm, Sepecer Capsules, Supportt-Bones Powder, and Supportt-Joint Powder. Its Skin Cure products include Acnea Gel, BanDruff Cream, Dermat Ointment, Fungi-Rid Capsules, Fungi-Rid Cream, Perfect Skin Syrup, PsoriBalm, and Dermat Ointment. Its general health products include BioSulf Powder, CC-99 Cough Syrup, Diabeteze Capsules, Frejomus Capsules, Gud-Hart Capsules, and Gud-Helth Capsules. Its Pain Relief products include Muscle Flex Capsules (with gold) and Muscle Flex Gel.
